Clinical significance of the K/DOQI bone guidelines in Japan.
Yokoyama
Keitaro
K
Katoh
Naohiko
N
Kubo
Hitoshi
H
Murai
Seizo
S
Imamura
Noritugu
N
Shoji
Ryo
R
Yamamoto
Hiroyasu
H
Shigematsu
Takashi
T
Nakayama
Masaaki
M
Takasu
Shinji
S
Kono
Takashi
T
Yoshida
Toyohiko
T
Hosoya
Tatsuo
T
D001800:Blood Specimen Collection; D001851:Bone Diseases, Metabolic / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000097:blood / Q000209:etiology; D007564:Japan; D007674:Kidney Diseases / Q000150:complications* / Q000378:metabolism / Q000628:therapy; D010281:Parathyroid Hormone / Q000097:blood; D010758:Phosphorus / Q000097:blood; D017410:Practice Guidelines as Topic; D012016:Reference Values; D013997:Time Factors; D014481:United States; D014807:Vitamin D / Q000008:administration & dosage / Q000627:therapeutic use*
D010281:Parathyroid Hormone; D014807:Vitamin D; D010758:Phosphorus